ANAB
Price
$20.36
Change
+$0.40 (+2.00%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
558.34M
76 days until earnings call
HRMY
Price
$38.04
Change
+$0.87 (+2.34%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
2.14B
69 days until earnings call
Interact to see
Advertisement

ANAB vs HRMY

Header iconANAB vs HRMY Comparison
Open Charts ANAB vs HRMYBanner chart's image
AnaptysBio
Price$20.36
Change+$0.40 (+2.00%)
Volume$5.31K
Capitalization558.34M
Harmony Biosciences Holdings
Price$38.04
Change+$0.87 (+2.34%)
Volume$1.85K
Capitalization2.14B
ANAB vs HRMY Comparison Chart in %
Loading...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANAB vs. HRMY commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a Buy and HRMY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (ANAB: $19.96 vs. HRMY: $37.17)
Brand notoriety: ANAB and HRMY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANAB: 62% vs. HRMY: 47%
Market capitalization -- ANAB: $558.34M vs. HRMY: $2.14B
ANAB [@Biotechnology] is valued at $558.34M. HRMY’s [@Biotechnology] market capitalization is $2.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANAB’s FA Score shows that 0 FA rating(s) are green whileHRMY’s FA Score has 0 green FA rating(s).

  • ANAB’s FA Score: 0 green, 5 red.
  • HRMY’s FA Score: 0 green, 5 red.
According to our system of comparison, HRMY is a better buy in the long-term than ANAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANAB’s TA Score shows that 5 TA indicator(s) are bullish while HRMY’s TA Score has 6 bullish TA indicator(s).

  • ANAB’s TA Score: 5 bullish, 5 bearish.
  • HRMY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, HRMY is a better buy in the short-term than ANAB.

Price Growth

ANAB (@Biotechnology) experienced а +0.86% price change this week, while HRMY (@Biotechnology) price change was +2.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.93%. For the same industry, the average monthly price growth was +13.93%, and the average quarterly price growth was +30.97%.

Reported Earning Dates

ANAB is expected to report earnings on Nov 11, 2025.

HRMY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+3.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRMY($2.14B) has a higher market cap than ANAB($558M). ANAB YTD gains are higher at: 50.755 vs. HRMY (8.021). HRMY has higher annual earnings (EBITDA): 265M vs. ANAB (-59.63M). HRMY has more cash in the bank: 565M vs. ANAB (266M). ANAB has less debt than HRMY: ANAB (15.1M) vs HRMY (172M). HRMY has higher revenues than ANAB: HRMY (773M) vs ANAB (123M).
ANABHRMYANAB / HRMY
Capitalization558M2.14B26%
EBITDA-59.63M265M-23%
Gain YTD50.7558.021633%
P/E RatioN/A11.99-
Revenue123M773M16%
Total Cash266M565M47%
Total Debt15.1M172M9%
FUNDAMENTALS RATINGS
ANAB: Fundamental Ratings
ANAB
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANABHRMY
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIEMX8.33N/A
N/A
Virtus SGA Emerging Markets Equity I
MPGFX181.40N/A
N/A
Mairs & Power Growth
QCSCX22.67N/A
N/A
Federated Hermes MDT Small Cap Core C
RYAKX59.25N/A
N/A
Rydex Russell 2000 1.5x Strategy A
GSAOX17.82N/A
N/A
Goldman Sachs Small Cap Gr Insghts A

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with SNBIF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then SNBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
-0.67%
SNBIF - HRMY
52%
Loosely correlated
N/A
CYTK - HRMY
37%
Loosely correlated
+3.19%
ANAB - HRMY
37%
Loosely correlated
-0.70%
LGND - HRMY
32%
Poorly correlated
+0.61%
AXON - HRMY
31%
Poorly correlated
+0.72%
More